Nasdaq grants Iveda 180-day extension to regain $1 minimum bid price compliance

• Nasdaq granted Iveda Solutions an extra 180 days, through March 1, 2027, to regain compliance with the $1 minimum bid rule.
• Stock must close at or above $1 for at least 10 consecutive business days during the extension to cure the deficiency.
• Nasdaq said the company met other continued-listing standards, including market value of publicly held shares.
• Management may consider a reverse stock split as a potential remedy, with no decision announced.
• The notice has no immediate impact on trading, with shares remaining listed on the Nasdaq Capital Market.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Iveda Solutions Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202609090700BIZWIRE_USPR_____20260909_BW443664) on September 09, 2026, and is solely responsible for the information contained therein.